SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
108 hedge funds and large institutions have $232M invested in scPharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
11% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 27
4.5% more ownership
Funds ownership: 72.35% → 76.85% (+4.5%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
108
Holding in Top 10
–
Calls
$5.69M
Puts
$983K
Top Buyers
| 1 | +$16.3M | |
| 2 | +$12.2M | |
| 3 | +$10.8M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$7.83M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$5.45M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.01M | |
| 3 | -$7.77M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
-$4.57M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.18M |
